Treatment patterns of hormone therapy for menopause-associated vasomotor symptoms: analysis of the HIRA database in South Korea

This study aimed to describe treatment patterns of hormone therapy (HT) prescribed for menopause-associated vasomotor symptoms (VMS), characteristics of women who received HT and events of interest using the Health Insurance and Review Assessment (HIRA) database in South Korea. Eligible patients were women aged 40–65 years who were first dispensed HT in 2015 and diagnosed with menopause-associated VMS. Patients were followed until death or the end of the data period, 31 December 2020, whichever occurred earlier. The analyses included 102,535 patients. Median age at VMS diagnosis was 52 years. Time from diagnosis to HT dispensation was